Reclaim Your Rise: Type 1 Diabetes with Lauren Bongiorno
Lauren Bongiorno is a Nationally Board Certified Health Coach and the founder and CEO of Risely Health. Featured on the TODAY show and other media outlets, Risely helps people and families impacted by Type 1 Diabetes take ownership over their health so they can transform their life with more freedom and confidence. Lauren has lived with type 1 diabetes since she was 7 years old and has experienced firsthand that when health transforms, so does everything else - our relationships, our time, our career, our families, and, most importantly, ourselves. Each week she will bring you lessons from her own personal diabetes experience, strategies that are key to understanding your body’s patterns, and guests who will speak to everything from advances in technology to all things hormones, exercise, relationships, and mindset. All of this so that over time, you TOO can reclaim your rise.
Reclaim Your Rise: Type 1 Diabetes with Lauren Bongiorno
96. Glucagon: busting the myths of this rescue drug to save lives and reform healthcare education with Xeris CEO Paul Edick
Ever heard someone say you only need glucagon when you’re passed out? In my sit down with Xeris CEO Paul Edick, we discussed the misperceptions and myths surrounding glucagon as a rescue prescription. From the lack of education within the healthcare community to the patients’ misinformation themselves, this is a call to action for patient advocacy and advocates to get everyone with diabetes on a rescue glucagon like Gvoke. That starts with learning proper usage and correct knowledge. This episode could save lives, and I am fully on board with sharing the Gvoke mission!
Time Stamps:
- (03:20) Paul’s journey to becoming CEO of Xeris and the “elegance” of Xeris technology
- (04:48) The growth of Xeris
- (06:41) What is glucagon?
- (07:56) The fallacy and myths around glucagon and its proper use.
- (09:32) Why did it take so long to innovate glucagon?
- (10:50) The statistics of hypoglycemia
- (12:33) What is considered a severe low and clinical trials
- (15:37) Using education to combat fears of glucagon and going low
- (18:15) The number one battle Xeris faces in getting Gvoke into more hands
- (20:16) Xeris’ role in educating the healthcare community on proper usage and knowledge
- (22:43) A Call to Action for patient advocacy and advocates
- (23:33) Standardized procedures for discussing rescue glucagon
- (26:00) What Xeris learned from bringing in social influencers to ask questions
- (29:08) The future of Xeris, their mission, and the startling statistical comparison to EpiPen for allergies
What to do now:
- Follow me @lauren_bongiorno and @riselyhealth on Instagram to stay in the loop for when new episodes drop.
- Learn more and apply for the January 2024 Decide and Conquer Bootcamp HERE.
Disclaimer: Nothing you hear on the Reclaim your Rise podcast should be a substitute for personalized professional medical advice. Please always consult your physician or other medical professional before making any changes to your diet, insulin dosages, or healthcare plan.
